Ditchcarbon
  • Customers
  1. Organizations
  2. Acceleron Pharma Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

Acceleron Pharma Inc.

Company website

Acceleron Pharma Inc., a leading biopharmaceutical company headquartered in the United States, focuses on developing innovative therapies for rare diseases and serious health conditions. Founded in 2004, Acceleron has made significant strides in the industry, particularly in the fields of pulmonary and muscle-related disorders. The company is renowned for its unique approach to harnessing the power of the Transforming Growth Factor-beta (TGF-β) superfamily, which underpins its core products, including the groundbreaking treatment for pulmonary arterial hypertension. With a strong commitment to research and development, Acceleron has positioned itself as a key player in the biopharmaceutical landscape, achieving notable milestones that underscore its dedication to improving patient outcomes.

Parent Company Available

We don't have data for Acceleron Pharma Inc., but we can show you information about their parent organization instead.

View parent company

Similar Organizations

EBIR

ES
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy